Neil Gregory Almstead, CHIEF TECHNICAL Operations OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 23,749 shares at $80.61 ($1.9M) on 2026-06-22, disclosed to the SEC on 2026-06-24.
Scheduled sale ($1.9M) by CHIEF TECHNICAL Operations OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.61 | 12,130 | $978K | 50.9% |
| 2 | $81.21 | 11,619 | $944K | 49.1% |
| Total | $80.90 avg | 23,749 | $1.9M | 100% |
| Filing → |
| PTCT | SELL | 2026-06-30 | $693K | — | Filing → |
| PTCT | SELL | 2026-06-26 | $2.3M | — | Filing → |
| PTCT | SELL | 2026-04-03 | $3.6M | — | Filing → |